Web Analytics

3 Latest Announced Rounds

  • $33,500,000
    Series B

    3 Investors

    Biotechnology Research
    Jan 14th, 2026
  • $1,863,303
    Pre-Seed

    2 Investors

    Software Development
    Jan 14th, 2026
  • $5,000,000
    Seed
    Pharmaceutical Manufacturing
    Jan 14th, 2026
$2,498.16M Raised in 48 Funding Rounds in the past 7 Days - View All

Funding Round Profile

CatalYm GmbH

start up
Germany - Martinsried, Bayern
  • 16/07/2024
  • Series D
  • $150,000,000

Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immune systems.


Related People

Phil L'HuillierFounder

Phil L'Huillier United Kingdom - Greater London, England

Specialties: CEO, Leadership, Corporate Development & strategy, Clinical Development, Business Development in biotechnology and pharmaceutical sectors